Bayer transforms pharma business through breakthrough innovation in healthcare 13:48 | 14/01/2021
Bayer has made exciting progress in transforming its pharmaceutical business with breakthrough innovations in healthcare that will significantly help patients suffering from conditions that are currently still difficult to treat.
Bayer highlighted its focus on cell, gene, and oncology pipelines during its virtual Pharma Media Day in Germany
The information was stressed at its virtual Pharma Media Day titled âTransforming Healthcare. Transforming Bayerâ in Germany. The event highlighted Bayer s focus on the cell, gene, and oncology pipelines.
âThe biomedical and technological revolution that is transforming healthcare at an unprecedented pace is taking place now. Our company is at the forefront of the wave of innovation in cell and gene therapy as well as digital health,â said Stefan Oelrich, member of the board of management at Ba
Bayer Updates Progress In Transforming Pharma Business Through Innovation In Healthcare
LEVERKUSEN (dpa-AFX) - Bayer AG Wednesday updated its progress in transforming its pharmaceutical business with breakthrough innovation in healthcare.
At its virtual Pharma Media Day, under the theme Transforming Healthcare. Transforming Bayer , the company revealed innovation in cell and gene therapy as well as digital health that will significantly help patients suffering from conditions that are currently still difficult to treat.
Bayer said it recently heavily invested in external innovation with more than 25 collaboration agreements and acquisitions.
Stefan Oelrich, Member of the Board of Management, Bayer AG and President of Bayer s Pharmaceuticals Division, said, We are driving this transformation and growing our promising development portfolio together with our partners. Our joint goal is to bring breakthrough treatments to patients and make healthcare systems more sustainable in the